|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 23 February 2021, 14:02. The announcement is not marked as price sensitive, and is 15 page(s) in length and 284.45kb in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.036% short sold according to ASIC data. It was ranked the 493rd most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| Appendix 2A | 23 February 2021, 14:02 |
| Half Year Report and Update | 22 February 2021, 9:00 |
| Appendix 4D and Interim Financial Report | 22 February 2021, 8:56 |
| Dimerix Plans for Next Study in Diabetic Kidney Disease | 28 January 2021, 8:34 |
You must be logged in to post a reply.
Dimerix 